Detalles de la búsqueda
1.
RPL35A is a key promotor involved in the development and progression of gastric cancer.
Cancer Cell Int
; 21(1): 497, 2021 Sep 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-34535139
2.
Acceptable but limited efficacy of capecitabine-based doublets in the first-line treatment of metastatic triple-negative breast cancer: a pilot study.
Chemotherapy
; 59(3): 207-13, 2013.
Artículo
en Inglés
| MEDLINE | ID: mdl-24335152
3.
The Prognostic Role of HuR Varies Between Different Subtypes of Breast Cancer Patients: Data Mining and Retrospective Analysis.
Breast Cancer (Dove Med Press)
; 15: 135-146, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36816839
4.
[Relationship between P-glycoprotein function in peripheral blood cells and multidrug resistance in breast carcinoma].
Zhonghua Zhong Liu Za Zhi
; 32(7): 529-32, 2010 Jul.
Artículo
en Zh
| MEDLINE | ID: mdl-21029698
5.
Polymorphisms in PARP1 predict disease-free survival of triple-negative breast cancer patients treated with anthracycline/taxane based adjuvant chemotherapy.
Sci Rep
; 10(1): 7349, 2020 04 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-32355298
6.
Polymorphisms in CLDN1 are associated with age and differentiation of triple-negative breast cancer patients.
Biosci Rep
; 39(4)2019 04 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-30910845
7.
Polymorphisms in AURKA and AURKB are associated with the survival of triple-negative breast cancer patients treated with taxane-based adjuvant chemotherapy.
Cancer Manag Res
; 10: 3801-3808, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-30288111
8.
Genetic variants in miRNA machinery genes associated with clinicopathological characteristics and outcomes of gastric cancer patients.
Int J Biol Markers
; 33(3): 301-307, 2018 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-29683064
9.
A Network Meta-analysis Comparing the Efficacy and Safety of Anti-PD-1 with Anti-PD-L1 in Non-small Cell Lung Cancer.
J Cancer
; 9(7): 1200-1206, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-29675101
10.
[Clinical features and prognostic factors of small breast cancer with multiple axillary lymph node metastasis].
Zhonghua Zhong Liu Za Zhi
; 29(8): 615-8, 2007 Aug.
Artículo
en Zh
| MEDLINE | ID: mdl-18210884
11.
MiRNA-27a promotes the proliferation and invasion of human gastric cancer MGC803 cells by targeting SFRP1 via Wnt/ß-catenin signaling pathway.
Am J Cancer Res
; 7(3): 405-416, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-28401000
12.
DROSHA rs10719 T>C is associated with lymph node metastasis and clinical stage of gastric cancer patients.
Int J Clin Exp Pathol
; 10(7): 7333-7339, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-31966573
13.
Polymorphism in miR-146a associated with clinical characteristics and outcomes in gastric cancer patients treated with adjuvant oxaliplatin and fluoropyrimidines.
Onco Targets Ther
; 8: 2627-33, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-26396533
14.
Antitumor activity of chloroquine in combination with Cisplatin in human gastric cancer xenografts.
Asian Pac J Cancer Prev
; 16(9): 3907-12, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-25987058
15.
Autophagy inhibition sensitizes cisplatin cytotoxicity in human gastric cancer cell line SGC7901.
Asian Pac J Cancer Prev
; 14(8): 4685-8, 2013.
Artículo
en Inglés
| MEDLINE | ID: mdl-24083726
16.
A retrospective study of metachronous and synchronous ipsilateral supraclavicular lymph node metastases in breast cancer patients.
Breast
; 19(5): 365-9, 2010 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-20399657
Resultados
1 -
16
de 16
1
Próxima >
>>